Healtech Tissue Engineering and Regenerative Medical Biomaterials Laboratory has undertaken the special project of "National 13th Five-Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", and has achieved the transformation of scientific and technological achievements in "Engineering Preparation Technology and Product Development of Low Immunogenicity Collagen and Silk Fibroin". It holds core patents for extracellular matrix(ECM) and silk fibroin(SFM), and has also developed various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, glucan, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.

The laboratory has developed over 80 technology projects, applied for 37 national patents, obtained 12 national invention patent certificates and 6 medical device registration certificates. It provides technical upgrades and new project reserves services for manufacturers and distributors, with strategic partnerships established globally with listed companies such as Fosun Pharma, Double Crane Pharma, and So-Young Group.